European Archives - Page 239 of 1538 - European Medical Journal

liver cancer

Coffee Intake Reduces Liver Cancer Risk

A major review suggests coffee’s bioactive compounds may help lower liver cancer risk, though benefits vary by intake, preparation method and individual lifestyle factors.

clinical trial

Virtual Clinical Trial Explores Psychedelics for Disorders of Consciousness

Researchers used a virtual clinical trial to test psychedelic responses in coma patients. Find out what they discovered.

psoriatic arthritis

Early Secukinumab Offers No Advantage Over Standard Psoriatic Arthritis Care

New study finds early use of secukinumab in psoriatic arthritis offers no significant advantage over standard step-up treatment after one year.

miscarriage

Major Review Maps the Non-Genetic Risks Linked to Miscarriage

Comprehensive umbrella review maps 227 non-genetic miscarriage risk factors, identifying 45 with suggestive evidence and highlighting urgent research gaps.

Treatment goals in PsA and axSpA

Psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) are two prototypic forms of immune-mediated inflammatory diseases (IMID)…

sepsis

Sepsis Programme Cuts Maternal Deaths and Severe Infections in Africa

New multicomponent programme reduces infection-related maternal deaths and severe illness in Malawi and Uganda by supporting early detection and treatment.

The Future of Bradykinin-Mediated Angioedema

This infographic provides an overview of bradykinin-mediated angioedema (AE-BK), including the biological pathways involved in bradykinin…

Children with IBS Struggle to Manage Their Treatment

A new longitudinal study finds that many adolescents with IBS struggle to manage complex treatment plans, highlighting key barriers to effective self-management.

27 Nov 2025

An Itchy Rash Under the Microscope

Explore a paediatric case of atopic dermatitis, and discover how patient treatment decisions in AD can be guided by a new European algorithm.

Antenatal Prebiotics Do Not Prevent Atopic Dermatitis in High-Risk Infants

A new trial finds maternal prebiotic supplementation during pregnancy does not prevent atopic dermatitis in high-risk infants at one year of age.